Advancing towards accurate phenotyping based on metabolic and fibrosis risk in metabolic-dysfunction associated steatotic liver disease: one step closer to personalized care

被引:0
|
作者
Munoz-Martinez, Sergio [1 ,2 ]
Jimenez-Masip, Alba [1 ,3 ]
Pericas, Juan M. [1 ,3 ,4 ]
机构
[1] Vall dHebron Hosp Univ, Liver Unit, Vall dHebron Inst Recerca VHIR, Liver Unit, Pg Vall dHebron 119-129, Barcelona 08035, Spain
[2] Univ Barcelona, Barcelona, Spain
[3] Univ Autonoma Barcelona, Barcelona, Spain
[4] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
关键词
Metabolic-dysfunction associated steatotic liver disease (MASLD); advanced fibrosis; type 2 diabetes (T2D); non-invasive tests (NITs); OUTCOMES; NAFLD;
D O I
10.21037/hbsn-23-563
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:128 / 131
页数:4
相关论文
共 50 条
  • [41] Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
    El-Kassas, Mohamed
    Awad, Abeer
    Elbadry, Mohamed
    Arab, Juan Pablo
    SEMINARS IN LIVER DISEASE, 2024, 44 (01) : 54 - 68
  • [42] Exploring autoantibodies as predictors of severe fibrosis or cirrhosis in metabolic dysfunction associated steatotic liver disease
    Ragheb, Mariam
    Van Iderstine, Micah Grubert
    Minuk, Gerald
    Faisal, Nabiha
    CANADIAN LIVER JOURNAL, 2024, 7 (02): : 291 - 298
  • [43] Comparing imaging modalities in the assessment of fibrosis in metabolic dysfunction-associated steatotic liver disease
    Ravanbakhsh, Naseem
    Browne, Debra
    Weaver, Carly
    Gholikhani, Asal
    Kavarian, Patil
    Mitsinikos, Tania
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 79 (06): : 1192 - 1198
  • [44] LIVER STIFFNESS MEASUREMENT AND HEPATOCELLULAR CARCINOMA RISK IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
    John, Binu
    Deng, Yangyang
    Singal, Amit
    Dahman, Bassam
    HEPATOLOGY, 2024, 80 : S768 - S769
  • [45] Predictors of mortality in hepatocellular cancer secondary to metabolic-dysfunction associated steatotic liver disease: a New Zealand cohort analysis
    Dyavadi, Vijay
    Swaminathan, Akhilesh
    Gane, Ed
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 108 - 109
  • [46] Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease
    Dong, Rui
    Tian, Ting
    Luo, Zhenghan
    Chang, Dongchun
    Xue, Hong
    Qu, Sen
    Wang, Jia
    Shen, Chao
    Zhang, Ru
    Wang, Jie
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2025, 35 (03)
  • [47] Different Associations of Coffee Consumption with the Risk of Incident Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Liver Fibrosis
    Lee, Jun-Hyuk
    Park, Jooyong
    Ahn, Sang Bong
    NUTRIENTS, 2024, 16 (01)
  • [48] The performance of the enhanced liver fibrosis test by cardiometabolic risk factors in patients with metabolic dysfunction-associated steatotic liver disease
    Kawata, Kazuhito
    Takahashi, Hirokazu
    Arai, Taeang
    Seko, Yuya
    Chida, Takeshi
    Noritake, Hiedenao
    Toyoda, Hidenori
    Hayashi, Hideki
    Yamaguchi, Kanji
    Iwaki, Michihiro
    Yoneda, Masato
    Shima, Toshihide
    Fujii, Hideki
    Morishita, Asahiro
    Tomita, Kengo
    Kawanaka, Miwa
    Yoshida, Yuichi
    Ikegami, Tadashi
    Notsumata, Kazuo
    Oeda, Satoshi
    Atsukawa, Masanori
    Kamada, Yoshihiro
    Sumida, Yoshio
    Fukushima, Hideaki
    Miyoshi, Eiji
    Aishima, Shinichi
    Okanoue, Takeshi
    Itoh, Yoshito
    Nakajima, Atsushi
    JOURNAL OF HEPATOLOGY, 2024, 80 : S537 - S538
  • [49] Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
    Zheng, Haixiang
    Sechi, Leonardo Antonio
    Navarese, Eliano Pio
    Casu, Gavino
    Vidili, Gianpaolo
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [50] Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease
    Mellemkjaer, Anders
    Kjaer, Mikkel Breinholt
    Haldrup, David
    Gronbaek, Henning
    Thomsen, Karen Louise
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 28 - 34